CYTK - Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024 | Benzinga
SOUTH SAN FRANCISCO, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced five presentations related to aficamten at the European Society of Cardiology Congress 2024, taking place in London, UK from August 30, 2024 – September 2, 2024.
Title: Effect of Aficamten on Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The SEQUOIA-HCM CMR Substudy
Presenter: Ahmad Masri, M.D., MS, Director of the Hypertrophic Cardiomyopathy Center at Oregon Health & Science University
Date: Augst 30, 2024
Topic: Infiltrative Myocardial Disease
Session Title: Cardiac Amyloidosis: Diagnosis and Outcomes
Session Type: Moderated ePosters
Session Time: 3:00-3:50 PM BST
Location: Station 10
Title: Clinical Application of Biomarkers in Obstructive Hypertrophic Cardiomyopathy: Insights from SEQUOIA-HCM
Presenter: Caroline Coats, M.D., Ph.D., Lead Clinician, West of Scotland Inherited Cardiac Conditions Service, Honorary Senior Lecturer, School of Cardiovascular and Metabolic Health, University of Glasgow
Date: September 1, 2024
Topic: Hypertrophic Cardiomyopathy
Session Title: Novel Therapies for Hypertrophic Cardiomyopathy - Recent Developments and Future Prospects
Session Type: Advances in Science
Session Time: 8:15-9:45 AM BST
Presentation Time: 8:51 AM BST
Location: Dublin
Title: Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy: An Integrated Safety Analysis
Presenter: Ahmad Masri, M.D., MS, Director of the Hypertrophic Cardiomyopathy Center at Oregon Health & Science University
Date: September 1, 2024
Topic: Hypertrophic Cardiomyopathy
Session Title: Novel Therapies for Hypertrophic Cardiomyopathy - Recent Developments and Future Prospects
Session Type: Advances in Science
Session Time: 8:15-9:45 AM BST
Presentation Time: 9:09 AM BST
Location: Dublin
Title: Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Presenter: Sheila Hegde, M.D., M.P.H., Cardiovascular Medicine Specialist, Division of Cardiovascular Medicine, Brigham and Women's Hospital
Date: September 2, 2024
Topic: Hypertrophic Cardiomyopathy